BackSigilon Therapeutics Overview

Sigilon Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SGTX.

Quarterly EBIT

-$6.92M
↑ 50.69% YoY

As of Jun 30, 2023

Annual EBIT (TTM)

-$30.32M
↑ 53.06% YoY

Trailing 12 months ending Jun 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin